EcoDrugPlus

Protein Kinase C Beta Type

Ensembl ID : ENSOMEG00000001893
Gene Symbol: LOC112137352
3 Cross references
223 Possible Orthologues:

Protein Kinase C Delta

Ensembl ID : ENSOMEG00000010377
Gene Symbol: PRKCD
3 Cross references
203 Possible Orthologues:

Protein Kinase C Epsilon

Ensembl ID : ENSOMEG00000017287
Gene Symbol: PRKCE
1 Cross references
246 Possible Orthologues:

Protein Kinase C Epsilon

Ensembl ID : ENSOMEG00000009065
Gene Symbol: PRKCE
3 Cross references
249 Possible Orthologues:

Protein Kinase C Eta

Ensembl ID : ENSOMEG00000006785
Gene Symbol: PRKCH
3 Cross references
224 Possible Orthologues:

Protein Kinase C Iota

Ensembl ID : ENSOMEG00000012129
Gene Symbol: PRKCI
3 Cross references
87 Possible Orthologues:

Protein Kinase C, Delta A

Ensembl ID : ENSOMEG00000009896
Gene Symbol: PRKCDA
1 Cross references
203 Possible Orthologues:

Protein Kinase C, Theta

Ensembl ID : ENSOMEG00000023735
Gene Symbol: PRKCQ
1 Cross references
203 Possible Orthologues:

Protein Kinase C, Zeta

Ensembl ID : ENSOMEG00000011568
Gene Symbol: PRKCZ
1 Cross references
201 Possible Orthologues:

Protein Kinase D1

Ensembl ID : ENSOMEG00000019479
Gene Symbol: PRKD1
3 Cross references
204 Possible Orthologues:

Protein Kinase D3

Ensembl ID : ENSOMEG00000015226
Gene Symbol: PRKD3
3 Cross references
209 Possible Orthologues:

Protein Kinase D3

Ensembl ID : ENSOMEG00000004454
Gene Symbol: PRKD3
3 Cross references
201 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).